BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 29311384)

  • 1. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
    Ostrand-Rosenberg S; Fenselau C
    J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasticity of myeloid-derived suppressor cells in cancer.
    Tcyganov E; Mastio J; Chen E; Gabrilovich DI
    Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid derived-suppressor cells: their role in cancer and obesity.
    Ostrand-Rosenberg S
    Curr Opin Immunol; 2018 Apr; 51():68-75. PubMed ID: 29544121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of myeloid derived suppressor cells in cancer from a biomarker perspective.
    Kalathil SG; Thanavala Y
    Cell Immunol; 2021 Mar; 361():104280. PubMed ID: 33445053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
    Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
    Front Immunol; 2019; 10():1401. PubMed ID: 31275327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
    Moses K; Brandau S
    Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy.
    Parker KH; Horn LA; Ostrand-Rosenberg S
    J Leukoc Biol; 2016 Sep; 100(3):463-70. PubMed ID: 26864266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells and tumor escape from immune surveillance.
    Umansky V; Blattner C; Fleming V; Hu X; Gebhardt C; Altevogt P; Utikal J
    Semin Immunopathol; 2017 Apr; 39(3):295-305. PubMed ID: 27787613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
    Xu W; Dong J; Zheng Y; Zhou J; Yuan Y; Ta HM; Miller HE; Olson M; Rajasekaran K; Ernstoff MS; Wang D; Malarkannan S; Wang L
    Cancer Immunol Res; 2019 Sep; 7(9):1497-1510. PubMed ID: 31340983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
    Qu P; Wang LZ; Lin PC
    Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.
    Zhou J; Nefedova Y; Lei A; Gabrilovich D
    Semin Immunol; 2018 Feb; 35():19-28. PubMed ID: 29254756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diversity of circulating neutrophils in cancer.
    Mishalian I; Granot Z; Fridlender ZG
    Immunobiology; 2017 Jan; 222(1):82-88. PubMed ID: 26874580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
    Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
    Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunobiology of myeloid-derived suppressor cells in cancer.
    Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M
    Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity and biological diversity of myeloid derived suppressor cells.
    Ben-Meir K; Twaik N; Baniyash M
    Curr Opin Immunol; 2018 Apr; 51():154-161. PubMed ID: 29614426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions.
    Geis-Asteggiante L; Belew AT; Clements VK; Edwards NJ; Ostrand-Rosenberg S; El-Sayed NM; Fenselau C
    J Proteome Res; 2018 Jan; 17(1):486-498. PubMed ID: 29139296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
    Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
    Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
    Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
    Front Immunol; 2018; 9():1288. PubMed ID: 29915603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.